1. Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
   Tim Patrick Ellerhoff et al, 2016 CrossRef
2. Measles Vaccine
   Diane E. Griffin, 2017, Viral Immunology CrossRef
3. Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene
   Can Yurttas et al, 2014, Human Gene Therapy Clinical Development CrossRef
4. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
   Gabriel Scheubeck et al, 2019, Viruses CrossRef
5. From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer
   Carolina S. Ilkow et al, 2014, PLoS Pathog CrossRef
6. “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene
   Can Yurttas et al, 2014, Human Gene Therapy Clinical Development CrossRef
7. Oncolysis by paramyxoviruses: preclinical and clinical studies
   Olga V Matveeva et al, 2015, Molecular Therapy - Oncolytics CrossRef
8. Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
   Benjamin Ruf et al, 2015, Molecular Therapy - Oncolytics CrossRef
9. Potential and clinical translation of oncolytic measles viruses
   Steven Robinson et al, 2017, Expert Opinion on Biological Therapy CrossRef
10. Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
    Chihab Klose et al, 2019, BMC Cancer CrossRef
11. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
    Tiphaine Delaunay et al, 2020, Journal of Thoracic Oncology CrossRef
12. Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
    Blake A. Jacobson et al, 2017, Oncotarget CrossRef
13. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
    Carole Achard et al, 2015, Oncotarget CrossRef
14. Mechanisms of measles virus oncolytic immunotherapy
    Gemma Pidelaserra-Martí et al, 2020, Cytokine & Growth Factor Reviews CrossRef
15. Suicide gene‑armed measles vaccine virus for the treatment of AML
    Stefanie Maurer et al, 2019, Int J Oncol CrossRef
16. Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus
    Verena May et al, 2019, Oncol Lett CrossRef
17. Measles virus in cancer therapy
    Michael D Mühlebach, 2020, Current Opinion in Virology CrossRef
18. Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines
    Susanne Berchtold et al, 2020, IJMS CrossRef
19. Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells
    Ching-Hsuan Liu et al, 2021, Cancers CrossRef
20. Measles Virus as an Oncolytic Immunotherapy
    Christine E. Engeland et al, 2021, Cancers CrossRef
21. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis
    Darshak K. Bhatt et al, 2021, Vaccines CrossRef
22. Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma
    Paul V. Ohnesorge et al, 2022, Cancers CrossRef
23. Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model
    Jana Koch et al, 2023, Viruses CrossRef
24. Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis
    Laura Menotti et al, 2023, IJMS CrossRef
25. Resistance in oncolytic viral therapy for solid tumors
    Prathibha Ambegoda-Liyanage et al, 2024, Applied Mathematics and Computation CrossRef
26. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus
    Nikolai V. Scheicher et al, 2024, Cancers CrossRef
27. null
    Mahalaxmi Iyer et al, 2024 CrossRef